Products for Research Use Only
RegisterLogin

Acimtamig

CAT: 0804-HY-P990710-01Size: 1 mgDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P990710-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Acimtamig (AFM13) is a CD30/CD16A bispecific innate cell engager. Acimtamig binds to the CD16A expressed on natural killer (NK) cells and binds to CD30 on CD30-expressing tumor cells, thereby selectively cross-linking tumor and NK cells. Acimtamig can be used for the study of eripheral T-cell lymphoma (PTCL) [1].
CAS Number
2738880-26-5
Product Name Alternative
AFM13
UNSPSC
12352203
Target
TNF Receptor
Type
Inhibitory Antibodies
Related Pathways
Apoptosis
Applications
COVID-19-immunoregulation
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/acimtamig.html
Purity
97.52
Smiles
[Acimtamig]
Molecular Weight
(103.936 kDa)
References & Citations
[1]Acimtamig|[2]Kim WS, et al. A Phase II Study of Acimtamig (AFM13) in Patients with CD30-Positive, Relapsed, or Refractory Peripheral T-cell Lymphomas. Clin Cancer Res. 2025 Jan 6;31 (1) :65-73.
Shipping Conditions
Dry Ice
Storage Conditions
-80°C
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 2

Alternative Products

CatalogName
MBS1580419-01Research Grade Acimtamig
GTR18695952-01Acimtamig Human Monoclonal Antibody
E55B1332Acimtamig (Reference antibody)
GTR18594915-01Acimtamig Biosimilar (FcgR3a / CD16a Reference Antibody)
PX-TA1981-01Acimtamig Biosimilar - Anti-CD30L receptor mAb - Research Grade
A136902Acimtamig Biosimilar (Monoclonal, IgG VH-V-kappa-VH'-V-lambda homodimer)

Popular Products